BioSpace News Archive

Following a change to U.S. corporate tax laws, Pfizer announced at the beginning of this year that it intends to invest $5 billion in U.S. manufacturing over the next five years. On Tuesday, Pfizer showed its commitment to that promise with a $465 million investment in a new Michigan manufacturing site that is expected to create more than 450 jobs.

Celgene announced data from its Phase III AUGMENT clinical trial that compared Revlimid (lenalidomide) and rituximab to placebo in relapsed/refractory follicular and marginal zone lymphoma.

The contract was awarded on November 1, 2017.

Second quarter revenues of $1.92 billion, up 3.0% from 2017

Total revenue was $155.9 million, an increase of $19.9 million, or 15%, compared with $136.0 million in the second quarter of 2017

Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the second quarter 2018 on Tuesday, Aug. 7 at 9 a.m. ET.

Draft LCD for use of Decipher in men with very low and low NCCN risk prostate cancer

Agreement to Benefit Millions of Chinese Consumers with Accurate, Trustworthy Content

2Q18 Reported EPS of $1.07

KEDPLASMA USA has added two additional plasma collection centers, one in College Park, Georgia, and another in Longview, Texas.